Strategies for Bioanalytical Method Development & Validation
Explore the strategies behind successful bioanalytical method development and validation for complex biologic therapies.
In this presentation, Erik Jerks discusses approaches to bioanalytical method development and validation, highlighting case studies involving bispecific multi-target antibodies and adeno-associated virus (AAV)-based therapies. He explores the challenges of developing robust bioanalytical assays and demonstrates how evolving technologies and automated instrumentation can help deliver high-quality, reliable solutions for complex drug development programs.